Market Leaders: DSM (Netherlands) and Fermenta Biotech Ltd. (India) Continue to Bring Innovative Solutions and Expand their Production Capacities Further to Strengthen their Presence in the Vitamin D Market
The vitamin D market size is estimated to be valued at USD 1.3 billion in 2022 and is projected to reach USD 1.9 billion by 2027, recording a CAGR of 7.1% during the forecast period in terms of value. Vitamin D is fat-soluble and is naturally present in various food products like mushrooms, cod liver oil, egg yolk, and salmon. The most abundant source of vitamin D is the sun’s ultraviolet rays. It stimulates calcium absorption in the gut and maintains adequate serum calcium and phosphate concentration to enable normal mineralization of bone and prevent hypocalcemic tetany. A deficiency of vitamin D may lead to diseases such as rickets in children, osteomalacia in adults, cancer, diabetes, and various chronic diseases in general demography. These are the major factors, which is fueling the vitamin D market in the pharmaceutical and personal care industry.
Key players in this market include DSM (Netherlands), Zhejiang Xinhecheng Co., Ltd. (China), Fermenta Biotech Ltd. (India), Dishman Group (India), Xiamen Jindawei Vitamin Co., Ltd. (China), Zhejiang Medicine Co., Ltd (China), PHW Group Lohmann & Co. (Germany), Sichuan Neijiang Huixin Pharmaceutical Co Ltd (China), BASF SE (Germany), Bio-Tech Pharmacal (US).
To know about the assumptions considered for the study download the pdf brochure
The existing players in the vitamin D market are focused on increasing their market shares. The top players in the market are concentrating on increasing their products, increasing their market presence, and uniting with various channel partners to offer to manufacturers across the globe. The vitamin D market has many organized players at the global level and unorganized players at the local level in several countries. The top players in the industry hold a market share of 65-70%.
DSM is one of the leading companies involved in the manufacture of nutritional & pharmaceutical ingredients, biomedical materials, thermoplastics, resins, and industrial chemicals. The products find application in various sectors, such as food & beverage, personal care, medical, textiles, pharmaceutical, feed, dietary supplements, electrics, automotive, paint, and construction. The company operates through three business segments, namely, nutrition, performance materials, and innovation center. It offers vitamin products under its nutrition division. The nutrition division comprises DSM Food Specialties and DSM Nutritional Products; DSM Nutritional Products offers vitamins for the feed, food, and pharmaceutical industries.
The company offers vitamin D3 dietary supplement Hy-D, ensuring that optimal levels of vitamin D3 are provided via diet. The company also manufactures ampli-D – an advanced and potent form of vitamin D in the dietary supplement market. Which was clinically proven to raise vitamin D levels three times faster and more effectively. Moreover, several strategic projects were introduced, such as the introduction of a fast-acting vitamin D form ampli-D. The company also executed on platform-based approach to driving innovation, resulting in good progress in a pipeline of exciting new products and solutions. Moreover, the company’s dairy business nevertheless increased, fuelled by sales of Hy•D, the pure and proprietary vitamin D3 metabolite that improves calcium management and lifetime productivity in dairy cows.
Fermenta Biotech Ltd. (India), Limited is one of the leading manufacturers of Vitamin D3 globally, headquartered in Thane, India. The company operates through three business segments—biotechnology, pharmaceuticals, and vitamin D3. It offers vitamin D3 for various applications such as pharmaceuticals, food, veterinary, and feed industries. It also provides vitamin D3 resin in oil and vitamin D3 500 feed-grade for use in the feed supplements and activated (Silicon Powder) for ant flatulent use.
Moreover, during the year under review, the company was granted multiple patents spanning from process improvements for Vitamin D to patents in the biotechnology space for antibiotics and antiviral synthesis using Fermenta’s proprietary enzymes.
Related Reports:
Vitamin D Market by Analog (Vitamin D2, Vitamin D3), Form (Dry, Liquid), Application (Feed & Pet Food, Pharma, Functional Food, and Personal Care), End Users (Adults, Pregnant Women, and Children), IU Strength and Region - Global Forecast to 2027
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
